T
Tim Davidson
Researcher at Royal Free Hospital
Publications - 35
Citations - 703
Tim Davidson is an academic researcher from Royal Free Hospital. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 13, co-authored 34 publications receiving 609 citations. Previous affiliations of Tim Davidson include Royal Free London NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Cancer Multidisciplinary Team Meetings: Evidence, Challenges, and the Role of Clinical Decision Support Technology
Vivek Patkar,Dionisio Acosta,Tim Davidson,Alison Jones,John Fox,M.R.S. Keshtgar,M.R.S. Keshtgar +6 more
TL;DR: A targeted summary of the available evidence on the impact of cancer MDT meetings is presented, the reported challenges are discussed, and the role that a CDS technology could play in addressing some of these challenges are explored.
Journal ArticleDOI
Religious/spiritual coping resources and their relationship with adjustment in patients newly diagnosed with breast cancer in the UK
TL;DR: The cross‐sectional data of a longitudinal study examining the beneficial and harmful effects of religious/spiritual coping resources on adjustment in the first year after a breast cancer diagnosis are reported.
Journal ArticleDOI
Religious coping strategies in patients diagnosed with breast cancer in the UK.
TL;DR: The prevalence of various religious coping strategies in a UK cancer sample was examined to examine the complexity of religious/spiritual coping and its potential to be adaptive as well as maladaptive.
Journal ArticleDOI
Using computerised decision support to improve compliance of cancer multidisciplinary meetings with evidence-based guidance
TL;DR: An interactive clinical decision support system called MATE (Multidisciplinary meeting Assistant and Treatment sElector) is developed to facilitate explicit evidence-based decision making in the breast MDMs to enhance the conduct of MDMs in a way that is acceptable to and valued by the clinical team.
Journal ArticleDOI
Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT.
Nathan J. Coombs,Joel M Coombs,Uma J Vaidya,Julian Singer,Max Bulsara,Jeffrey S Tobias,Frederik Wenz,David Joseph,Douglas Brown,Richard M. Rainsbury,Tim Davidson,Douglas Adamson,Samuele Massarut,David A.L. Morgan,Ingrid Potyka,Tammy Corica,Mary Falzon,Norman R. Williams,Michael Baum,Jayant S. Vaidya +19 more
TL;DR: The use of TARGIT intraoperative radiotherapy for eligible patients with breast cancer significantly reduces their journeys for treatment and has environmental benefits.